Omega-3 Fatty Acids (Fish Oil) Supplementation and Albuminuria: Not a Slam Dunk
- PMID: 28710179
- PMCID: PMC5586308
- DOI: 10.1161/JAHA.117.006020
Omega-3 Fatty Acids (Fish Oil) Supplementation and Albuminuria: Not a Slam Dunk
Keywords: Editorials; clinical trial; fish oil; glomerular filtration rate; kidney (diabetes); microalbumin.
Comment on
-
Eicosapentaenoic and Docosahexaenoic Acids Attenuate Progression of Albuminuria in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease.J Am Heart Assoc. 2017 Jul 14;6(7):e004740. doi: 10.1161/JAHA.116.004740. J Am Heart Assoc. 2017. PMID: 28710178 Free PMC article. Clinical Trial.
Similar articles
-
Are krill oil supplements a better source of n-3 fatty acids than fish oil supplements?J Acad Nutr Diet. 2012 Feb;112(2):344. doi: 10.1016/j.jand.2011.12.016. Epub 2012 Jan 25. J Acad Nutr Diet. 2012. PMID: 22459227 No abstract available.
-
Eicosapentaenoic and Docosahexaenoic Acids Attenuate Progression of Albuminuria in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease.J Am Heart Assoc. 2017 Jul 14;6(7):e004740. doi: 10.1161/JAHA.116.004740. J Am Heart Assoc. 2017. PMID: 28710178 Free PMC article. Clinical Trial.
-
Effect of randomized supplementation with high dose olive, flax or fish oil on serum phospholipid fatty acid levels in adults with attention deficit hyperactivity disorder.Reprod Nutr Dev. 2005 Sep-Oct;45(5):549-58. doi: 10.1051/rnd:2005045. Reprod Nutr Dev. 2005. PMID: 16188207 Clinical Trial.
-
Omega-3 Polyunsaturated Fatty Acid (Fish Oil) Supplementation and the Prevention of Clinical Cardiovascular Disease: A Science Advisory From the American Heart Association.Circulation. 2017 Apr 11;135(15):e867-e884. doi: 10.1161/CIR.0000000000000482. Epub 2017 Mar 13. Circulation. 2017. PMID: 28289069 Free PMC article. Review.
-
Omega-3 Fatty Acids and Maternal and Child Health: An Updated Systematic Review.Evid Rep Technol Assess (Full Rep). 2016 Oct;(224):1-826. doi: 10.23970/AHRQEPCERTA224. Evid Rep Technol Assess (Full Rep). 2016. PMID: 30307735
Cited by
-
Are Nutraceuticals Beneficial in Chronic Kidney Disease?Pharmaceutics. 2021 Feb 6;13(2):231. doi: 10.3390/pharmaceutics13020231. Pharmaceutics. 2021. PMID: 33562154 Free PMC article. Review.
-
The effects of omega-3 fatty acids on diabetic nephropathy: A meta-analysis of randomized controlled trials.PLoS One. 2020 Feb 11;15(2):e0228315. doi: 10.1371/journal.pone.0228315. eCollection 2020. PLoS One. 2020. PMID: 32045421 Free PMC article.
References
-
- Mozaffarian D, Wu JH. Omega‐3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. J Am Coll Cardiol. 2011;58:2047–2067. - PubMed
-
- Shapiro H, Theilla M, Attal‐Singer J, Singer P. Effects of polyunsaturated fatty acid consumption in diabetic nephropathy. Nat Rev Nephrol. 2011;7:110–121. - PubMed
-
- Casanova MA, Medeiros F, Trindade M, Cohen C, Oigman W, Neves MF. Omega‐3 fatty acids supplementation improves endothelial function and arterial stiffness in hypertensive patients with hypertriglyceridemia and high cardiovascular risk. J Am Soc Hypertens. 2017;11:10–19. - PubMed
-
- Siscovick DS, Barringer TA, Fretts AM, Wu JH, Lichtenstein AH, Costello RB, Kris‐Etherton PM, Jacobson TA, Engler MB, Alger HM, Appel LJ, Mozaffarian D; American Heart Association Nutrition Committee of the Council on Lifestyle and Cardiometabolic Health, Council on Epidemiology and Prevention, Council on Cardiovascular Disease in the Young, Council on Cardiovascular and Stroke Nursing, and Council on Clinical Cardiology . Omega‐3 polyunsaturated fatty acid (fish oil) supplementation and the prevention of clinical cardiovascular disease: a science advisory from the American Heart Association. Circulation. 2017;135:e867–e884. - PMC - PubMed
-
- Fassett RG, Gobe GC, Peake JM, Coombes JS. Omega‐3 polyunsaturated fatty acids in the treatment of kidney disease. Am J Kidney Dis. 2010;56:728–742. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources